MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Price to Book (2021 - 2022)

Updated

MiNK Therapeutics' (INKT) Price to Book was 10.55 for Q3 2022, up 203.3% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Price to Book (2021 - 2022) Analysis & Trends

For FY2021, Price to Book at MiNK Therapeutics was 4.88.

  • Per Business Quant data, the three quarters before Q3 2022 came in at 3.48 (Q2 2022), 4.36 (Q1 2022) and 4.88 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 MiNK Therapeutics 56.61 Mn 15.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 10.55
Jun 30, 2022 3.48
Mar 31, 2022 4.36
Dec 31, 2021 4.88
API Access

MiNK Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=INKT&period=max&api_key=YOUR_API_KEY